About
Therapies for prevalent, degenerative diseases as well as sustained-release drug delivery systems
Areas of Focus
Categories
Small Molecule PharmaceuticalDrug Delivery & FormulationBoston & New England
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
0
As Collaborator
4
Total Enrollment
49
By Phase
PHASE1: 3PHASE1/PHASE2: 1
By Status
RECRUITING: 3COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06781255Collaborator
Evaluation of K9 in Subjects With Diabetic Macular Edema (DME)
PHASE1Recruiting
5 participants
Started: Mar 13, 2025 · Completed: Jul 31, 2027
NCT06467435Collaborator
Evaluation of K9 in Subjects With Thyroid Eye Disease (TED)
PHASE1Recruiting
13 participants
Started: Nov 6, 2024 · Completed: Aug 31, 2027
NCT06164587Collaborator
Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy
PHASE1/PHASE2Recruiting
30 participants
Started: Apr 18, 2024 · Completed: Dec 31, 2027
NCT05699759Collaborator
Safety and Effect of Intravitreal Injection of a Derivative of Nucleoside Reverse Transcriptase Inhibitor in Subjects with Diabetic Macular Edema
PHASE1Completed
1 participants
Started: Jan 4, 2024 · Completed: Jun 20, 2024
Locations (1)
Headquarters
Newton, MA, United States
Map
Loading map...